SEB raises target for Coloplast stock to DKK 515.00

Published on 10/20/2026 at 21:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due November 3, 2026, with 21 analysts. Coloplast stock costs EUR 63.46 on October 20, 2026 after DKK 476.00 in Copenhagen.

Analyst target and dates

SEB raised its Coloplast target from DKK 500.00 to DKK 515.00 on October 19, 2026.
Coloplast is scheduled to publish annual results on November 3, 2026.
Coloplast stock costs EUR 63.46 at Lang & Schwarz on October 20, 2026 at 9:12 p.m. CEST.
The price-to-earnings ratio is 38.83.

Reinraum-Produktion medizinischer Versorgungsprodukte in heller Fertigungshalle — Coloplast A/S (DK0060448595) zeigt hier moderne sterile Produktion medizinischer Versorgungsprodukte in heller Fertigungshalle, Illustration mit AI erstellt.

SEB raised its target for Coloplast stock from DKK 500.00 to DKK 515.00 on October 19, 2026, according to MarketScreener. Coloplast stock was trading at EUR 63.46 at Lang & Schwarz on October 20, 2026 at 9:12 p.m. CEST, after the Xetra session.

SEB sets a higher target

The new DKK 515.00 target is 8.19 percent above the DKK 476.00 last price on Nasdaq Copenhagen at 4:59 p.m. CEST on October 20, 2026. SEB kept its buy recommendation, while the market-wide analyst view remains more cautious.

MarketScreener lists 21 analysts and an average target of DKK 463.52. That average sits below the DKK 476.00 Copenhagen quote, making SEB's DKK 515.00 target the more optimistic recent published view.

Stock remains below its yearly high

Coloplast's Nasdaq Copenhagen quote stood at DKK 476.00 on October 20, 2026. Its 52-week range was DKK 369.70 to DKK 631.40, placing the stock 24.62 percent below the yearly high and 28.74 percent above the yearly low. The market capitalization was DKK 107.3 billion, and trading volume reached 281,778 shares.

What comes next for Coloplast?

Coloplast is scheduled to publish its annual results on November 3, 2026, according to MarketScreener. The report will give investors a fresh operating reference before the next round of target revisions. The current valuation shows a price-to-earnings ratio of 38.83, so the annual figures will be important for judging whether earnings growth supports that multiple.

Price and valuation in view

Coloplast combines a DKK 107.3 billion market value with a 38.83 price-to-earnings ratio and a DKK 515.00 recent target from SEB. The spread between the DKK 463.52 average target and the DKK 515.00 SEB target shows how differently analysts assess the company's earnings path.

At Lang & Schwarz, Coloplast stock was trading at EUR 63.46 on October 20, 2026 at 9:12 p.m. CEST, after the Xetra session. The DKK 476.00 Copenhagen quote provides the separate home-market view for the same trading date.

The further course of trading is shown by the continuously updated real-time quote of Coloplast stock.